Fri, Dec 19, 2014, 11:54 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

BioLineRx, Ltd. (BLRX) Message Board

phoenixbuds 3 posts  |  Last Activity: 14 hours ago Member since: Jul 11, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    What am I missing here?

    by phoenixbuds Dec 18, 2014 4:03 PM
    phoenixbuds phoenixbuds 14 hours ago Flag

    Stocks are bought and sold on expectation. In MNDO's case where there is no long term debt, a solid dividend paying policy, and the prospects for greater sales, based on these assumptions, the price should rise to meet these expectations. The Shekel is pegged to the dollar, which means that as the dollar rises so does the shekel. I am assuming that the price of MNDO is down simply due to profit taking for this year. Once the the time period to sell stocks in 2014 is over, MNDO will rise once again to test the new highs set just 10 days ago.

    Sentiment: Strong Buy

  • phoenixbuds by phoenixbuds Dec 18, 2014 4:03 PM Flag

    The Dow is up 403 points and this stock is down 11 cents. No long term debt, solid earnings, a superb management team, yet the stock has been trading down for the past week. Is there a big negative lurking out there that only management knows about? MNDO should be selling for $7 to 10 dollars by now.

    Sentiment: Strong Buy

  • MIND an Israeli company that has no long term debt, and pays a solid dividend. MIND is in a growth industry that plans on growing. If you are on a fixed income and now a stock comes along and pays something greater than 1-2% that is available elsewhere, makes MIND a terrific stock to own. My feeling is that MIND is either a takeover candidate, or it is clearly a $10 stock with several splits in between.

    Sentiment: Strong Buy

BLRX
1.72+0.03(+1.78%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.